TrialThe journal of allergy and clinical immunology. In practice

Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.

Fei Li Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.